Tech Company Financing Transactions
Delfi Diagnostics Funding Round
Delfi Diagnostics secured a $225 million Series B funding round on 7/18/2022. Backers included DFJ Growth, AV8 Ventures and Brown Advisory.
Transaction Overview
Company Name
Announced On
7/18/2022
Transaction Type
Venture Equity
Amount
$225,000,000
Round
Series B
Investors
DFJ Growth (Lead Investor) (Justin Kao)
Proceeds Purpose
This funding will support the continued development and commercialization of high-quality and accessible blood tests for single cancer early detection, multi-cancer early detection, and treatment monitoring.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
301 W. 29th St.
Baltimore, MD 21211
USA
Baltimore, MD 21211
USA
Phone
Website
Email Address
Overview
Founded in 2019, Delfi Diagnostics is committed to developing high-performing, affordable blood tests for early detection of cancer across multiple tumor types. Leveraging recent advances in cancer biology and machine learning, DELFI's technology can achieve high performance from low-cost, widely available sequencing technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Victor Velculescu
Chief Financial Officer
William Stevens
Chief Operating Officer
Jenn Buechel
Chief Scientific Officer
Nic Dracopoli
VP - Regulatory Affairs
Mya Thomae
Browse more venture capital transactions:
Prev: 7/18/2022: Syrius Robotics venture capital transaction
Next: 7/18/2022: Arch Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs